What is the translation of " WERE RANDOMISED " in Croatian?

• bilo randomizirano
• su bili randomizirani
• bilo je randomizirano
• randomiziranih
• nasumce je
• je randomizirano
• bila su randomizirana
• su bile randomizirane
• su randomizirane
• su randomizirana

Examples of using Were randomised in English and their translations into Croatian

A total of 820 patients were randomised.
Ukupno je randomizirano 820 bolesnika.

A total of 704 subjects were randomised 1:1 to either combination or vemurafenib.
Randomizirano je ukupno 704 ispitanika u omjeru 1:1 ili na kombinaciju ili na vemurafenib.

A total of 79 patients with symptomatic MCD were randomised and treated.
Ukupno je randomizirano i liječeno 79 bolesnika sa simptomatskom MCD.

A total of 1528 patients were randomised in equal proportions to the following two arms.
Ukupno je randomizirano 1528 bolesnica u jednakim omjerima u sljedeće dvije skupine.

Patients were randomised into the study a median of 40 days after completing their final platinum chemotherapy.
Bolesnice su bile randomizirane za sudjelovanje u ispitivanju 40 dana(medijan) nakon završetka posljednje kemoterapije platinom.

A total of 358 patients were randomised and treated.
Ukupno je 358 bolesnika bilo randomizirano i liječeno.

These studies were randomised and double blind, which usually means we can trust them.
Studije su bile randomizirane i dvostruko-slijepe, što obično znači da će dati pouzdane rezultate.

A total of 1,106 patients were randomised, 553 to each arm.
Ukupan broj od 1106 bolesnika je randomiziran po 553 ispitanika u svaki krak.

Patients were randomised in a 1:1:1 ratio to one of the three treatment groups and stratified by HCV genotype 1a versus 1b.
Pacijenti su bili randomizirani u omjeru 1:1:1 u jednu od tri terapijske skupine i stratificirani prema genotipu HCV-a 1a naspram 1b.

A total of 452 patients were randomised to receive either.
Ukupno su randomizirane 452 bolesnice, da primaju jedan od sljedećih protokola.

Patients were randomised in a 2:2:1 ratio to receive 8 mg every 2 weeks or every 4 weeks or placebo for 6 months.
Bolesnici su bili randomizirani u omjeru 2:2:1 kako bi primali 8 mg svaka 2 tjedna ili svaka 4 tjedna ili placebo tijekom 6 mjeseci.

Safety was assessed for patients who were randomised to receive pemetrexed N 800.
Napravljena je procjena sigurnosti u bolesnika randomiziranih da primaju pemetreksed N 800.

Patients were randomised in a 2:1 ratio to receive an intravenous infusion of Cyramza 8 mg/kg(n= 238) or placebo(n= 117) every 2 weeks.
Bolesnici su bili randomizirani u omjeru 2:1 za primanje intravenske infuzije lijeka Cyramza u dozi od 8 mg/kg(n=238) ili placeba(n=117) svaka dva tjedna.

During the randomised period of the study, subjects were randomised by 3 age cohort strata(2:1) to eltrombopag(n=45) or placebo n=22.
Tijekom randomiziranog razdoblja ispitivanja ispitanici su bili randomizirani prema 3 stratuma dobnih kohorti(2:1) na eltrombopag(n=45) ili placebo n=22.

Subjects were randomised to receive either one 1,662,500 IU capsule of colistimethate sodium twice daily, or 300 mg of tobramycin, twice daily.
Ispitanici su bili randomizirani tako da su dobivali jednu kapsulu s 1 662 500 IU kolistimetatnatrija dvaput dnevno, ili 300 mg tobramicina dvaput dnevno.

A total of 63 patients were randomised 43 on pramipexole, 20 on placebo.
Ukupno su bila randomizirana 63 bolesnika 43 je bilo na pramipeksolu, 20 na placebu.

Patients were randomised in a 2:1 ratio to either switch to Stribild or stay on their baseline antiretroviral regimen(SBR) for 48 weeks.
Pacijenti su bili randomizirani u omjeru 2:1 kako bi prešli na Stribild ili ostali na početnom antiretrovirusnom režimu(engl. stayed on baseline regimen, SBR) tijekom 48 tjedana.

A total of 1873 patients were randomised in equal proportions to the following three arms.
Ukupno su randomizirane 1873 bolesnice u jednakim omjerima u sljedeće tri skupine.

Patients were randomised to receive either 24 mg/m2 body surface area(BSA) of Humira up to a maximum of 40 mg, or placebo every other week for 12 weeks.
Bolesnici su bili randomizirani i primali su ili 24 mg/m2 tjelesne površine lijeka Humira do maksimalne doze od 40 mg ili placebo svaki drugi tjedan tijekom 12 tjedana.

In this study, 212 patients were randomised and received either palifermin or placebo.
U ovom ispitivanju 212 bolesnika je randomizirano i primilo ili palifermin, ili placebo.

Both studies were randomised, parallel-group, double-blind, multinational trials in patients with symptomatic proximal DVT or symptomatic PE.
Oba ispitivanja bila su randomizirana, dvostruko slijepa, multinacionalna, s paralelnim skupinama, u bolesnika sa simptomatskom proksimalnom dubokom venskom trombozom ili simptomatskom plućnom embolijom.

A total of 117 patients were randomised, 78 to Votubia and 39 to placebo.
Ukupno je 117 bolesnika bilo randomizirano, 78 na primanje Votubie i 39 na primanje placeba.

Five-hundred and sixty-five patients were randomised to receive an initial dose of Ranexa 500 mg twice daily or placebo for 1 week, followed by 6 weeks of treatment with Ranexa 1000 mg twice daily or placebo, in addition to concomitant treatment with amlodipine 10 mg once daily.
Petsto šezdeset pet bolesnika nasumce je odabrano da primaju početnu dozu Ranexe 500 mg dvaput dnevno ili placebo tijekom 1 tjedna, nakon čega je slijedilo 6 tjedana liječenja s 1000 mg dvaput dnevno ili placebom, uz istovremeno liječenje s 10 mg amlodipina jednom dnevno.

A total of 63 patients were randomised 43 on pramipexole, 20 on placebo.
Ukupno je 63 bolesnika bilo randomizirano 43 je bilo na pramipeksolu, 20 na placebu.

A total of 2,312 children and adolescents were randomised by site at a 3:1:1 ratio to receive either Fluenz Tetra or one of two formulations of comparator vaccine Fluenz, each containing a B strain that corresponded to one of the two B strains in Fluenz Tetra a B strain of the Yamagata lineage and a B strain of the Victoria lineage.
Ukupno 2, 312 djece i adolescenata randomiziranih u omjeru 3:1:1 prema dobivanju cjepiva Fluenz Tetra ili jedne od dvije formulacije cjepiva Fluenz, od kojih svaka sadrži tip B soj koji odgovara jednom od dvaju tip B sojeva u cjepivu Fluenz Tetra tip B soj linije Yamagata i tip B soj linije Victoria.

In this study 277 patients were randomised in a 2:2:1 ratio to the following arms.
U ovom ispitivanju bilo je randomizirano 277 bolesnika u omjeru 2:2:1 u jednu od sljedećih skupina.

In total 620 patients were randomised to one of the three treatment groups, of which 504(81%) patients completed the study.
Od ukupno 620 bolesnika randomiziranih u jednu od tri skupine liječenja, ispitivanje je završilo njih 504 81.

A total of 118 patients were randomised, 79 to Votubia 10 mg daily and 39 to placebo.
Ukupno je 118 bolesnika bilo randomizirano, 79 na 10 mg Votubie dnevno i 39 na placebo.

A total of 198 patients were randomised to receive pasireotide intramuscular use 40 mg(n=65), pasireotide intramuscular use 60 mg(n=65) or active control n=68.
Ukupno je 198 bolesnika bilo randomizirano na primanje pasireotida 40 mg intramuskularno(n=65), pasireotida 60 mg intramuskularno(n=65) ili aktivne kontrole n=68.

In the HORIZON-RFT study 508 men were randomised into the study and 185 patients had BMD assessed at 24 months.
U HORIZON-RFT ispitivanju bilo je randomizirano 508 muškaraca i u 185 bolesnika BMD je bio procijenjen u 24. mjesecu.